BiotechTube

Lobradimil + Amphotericin B

Phase 1Completed
0 watching 0 views this week💤 Quiet
30
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Meningitis, Cryptococcal

Conditions

Meningitis, Cryptococcal, HIV Infections

Trial Timeline

— → —

NCT ID
NCT00002316

About Lobradimil + Amphotericin B

Lobradimil + Amphotericin B is a phase 1 stage product being developed by Alkermes for Meningitis, Cryptococcal. The current trial status is completed. This product is registered under clinical trial identifier NCT00002316. Target conditions include Meningitis, Cryptococcal, HIV Infections.

Hype Score Breakdown

Clinical
10
Activity
5
Company
7
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT00002316Phase 1Completed

Competing Products

20 competing products in Meningitis, Cryptococcal

See all competitors
ProductCompanyStageHype Score
RotaTeq® + NeisVac-C®MerckPhase 3
77
DaptomycinMerckPre-clinical
23
Meningococcal ACWY conjugate vaccineNovartisPhase 3
77
Placebo + Combined Tetanus, Reduced Diphtheria Toxoid, Acellular Pertussis Vaccine + Quadrivalent Human Papillomavirus Vaccine + MenACWY-CRM Conjugate Vaccine + Combined Tetanus, Reduced Diphtheria Toxoid, Acellular Pertussis Vaccine + Quadrivalent Human Papillomavirus VaccineNovartisApproved
85
Meningococcal ACWY Conjugate Vaccine + DTaP-IPV-HBV + Hib + Rotavirus + Pneumococcal 7-valent Conjugate Vaccine + HAV + MMR-V + DTaPNovartisPhase 3
77
Meningococcal (Groups A, C, Y and W-135) Conjugate + Meningococcal polysaccharide A, C, Y and W135 and MenveoNovartisPhase 3
77
Meningococcal ACWY conjugate vaccineNovartisPhase 3
77
MenACWY-CRM + MenC-CRM + DTaP-Hib-IPV + PC7 + MMR + VaricellaNovartisPhase 2
52
Hib-CRM197 + Hib-TTNovartisPhase 3
77
Novartis Meningococcal ACWY Conjugate Vaccine + Tdap Vaccine + Novartis Meningococcal ACWY Conjugate VaccineNovartisPhase 3
77
MenACWY-CRM conjugate vaccine, adjuvanted + MenACWY polysaccharide vaccine + MenACWY-CRM conjugate vaccine, unadjuvantedNovartisPhase 2
52
meningococcal B vaccine & meningococcal ACYW conjugate vaccineNovartisPhase 2
52
Efungumab (Mycograb) + placebo + Amphotericin B + 5 flucytosineNovartisPhase 2
52
4CMenBNovartisApproved
85
Meningococcal (groups A, C, W, and Y) oligosaccharide diphtheria CRM-197 conjugate vaccineNovartisPhase 3
77
Meningococcal (group B) multicomponent recombinant adsorbed vaccineNovartisPhase 3
77
MenACWY-CRM197 (two doses) + MenC + PCV7 + DTPa-IPV-HepB-Hib + MenACWY-CRM197 (one dose)NovartisPhase 3
77
MenACWY-CRM197 + DTaP (Diptheria, Tetanus, Pertussis) Vaccine + Hib (Haemophilus influenza b) Vaccine + IPV (Inactivated Polio Vaccine) Vaccine + Pneumococcal conjugate Vaccine + MMR (Measles, Mumps, and Rubella) Vaccine + Varicella Vaccine + Hepatitis A VirusNovartisPhase 3
77
Meningococcal ACWY Polysaccharide Vaccine + MenACWY CRM (19 to 55 years) + Meningococcal ACWY Conjugate Vaccine + Novartis MenACWY Vaccine (56 to 65 Years)NovartisPhase 3
77
Meningococcal B vaccine + Meningococcal B vaccine + Meningococcal B vaccine + Meningococcal B vaccine + Meningococcal B vaccine + Meningococcal B vaccine + Control + Meningococcal B vaccine with antipyreticNovartisPhase 2
52

Other Products from Alkermes

Naltrexone for extended-release injectable suspension + Oral naltrexoneApproved
82
XR-NTX 380 mg, intramuscular injection + Placebo intramuscular injectionApproved
82
Aripiprazole LauroxilApproved
82
VIVITROL 380 mg + PlaceboApproved
82
Aripiprazole LauroxilApproved
82